您的账号已在其他设备登录,您当前账号已强迫下线,
如非您本人操作,建议您在会员中心进行密码修改

确定
收藏 | 浏览141

We tested the hypothesis that heart rate (HR) reduction with ivabradine (IVA) leads to reversal of structural, biochemical, and molecular maladaptations characteristic of the heart failure (HF) state. HR reduction with IVA has been shown to improve left ventricular (LV) systolic function and clinical outcome in patients with HF.Studies were performed in 16 HF dogs produced by intracoronary microembolizations [LV ejection fraction (EF) ~35

作者:Hani N, Sabbah;Ramesh C, Gupta;Smita, Kohli;Mengjun, Wang;Kefei, Zhang;Sharad, Rastogi

来源:ESC heart failure 2014 年 1卷 2期

知识库介绍

临床诊疗知识库该平台旨在解决临床医护人员在学习、工作中对医学信息的需求,方便快速、便捷的获取实用的医学信息,辅助临床决策参考。该库包含疾病、药品、检查、指南规范、病例文献及循证文献等多种丰富权威的临床资源。

详细介绍
热门关注
免责声明:本知识库提供的有关内容等信息仅供学习参考,不代替医生的诊断和医嘱。

收藏
| 浏览:141
作者:
Hani N, Sabbah;Ramesh C, Gupta;Smita, Kohli;Mengjun, Wang;Kefei, Zhang;Sharad, Rastogi
来源:
ESC heart failure 2014 年 1卷 2期
标签:
Gene expression Heart failure Heart rate Inflammatory cytokines Ventricular remodelling
We tested the hypothesis that heart rate (HR) reduction with ivabradine (IVA) leads to reversal of structural, biochemical, and molecular maladaptations characteristic of the heart failure (HF) state. HR reduction with IVA has been shown to improve left ventricular (LV) systolic function and clinical outcome in patients with HF.Studies were performed in 16 HF dogs produced by intracoronary microembolizations [LV ejection fraction (EF) ~35